切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (03) : 273 -277. doi: 10.3877/cma.j.issn.1674-134X.2022.03.003

临床论著

全膝关节置换术中氨甲环酸联合罗哌卡因骨膜下注射效果
林涌生1,(), 林志斌1, 李扬1, 陈宏1, 陈松亮1   
  1. 1. 522000 广东省揭阳市人民医院骨外一科
  • 收稿日期:2021-03-23 出版日期:2022-06-01
  • 通信作者: 林涌生
  • 基金资助:
    广东省揭阳市科技计划项目(ylxm072)

Effects of subperiosteal injection of tranexamic acid combined with ropivacaine in total knee arthroplasty

Yongsheng Lin1,(), Zhibin Lin1, Yang Li1, Hong Chen1, Songliang Chen1   

  1. 1. The No.1 Department of Orthopedics, Jieyang People's Hospital, Jieyang 522000, China
  • Received:2021-03-23 Published:2022-06-01
  • Corresponding author: Yongsheng Lin
引用本文:

林涌生, 林志斌, 李扬, 陈宏, 陈松亮. 全膝关节置换术中氨甲环酸联合罗哌卡因骨膜下注射效果[J/OL]. 中华关节外科杂志(电子版), 2022, 16(03): 273-277.

Yongsheng Lin, Zhibin Lin, Yang Li, Hong Chen, Songliang Chen. Effects of subperiosteal injection of tranexamic acid combined with ropivacaine in total knee arthroplasty[J/OL]. Chinese Journal of Joint Surgery(Electronic Edition), 2022, 16(03): 273-277.

目的

探讨骨膜下注射氨甲环酸(TXA)联合罗哌卡因在单侧全膝关节置换术(TKA)中应用的疗效。

方法

回顾性对比分析2017年1月至2021年1月于广东省揭阳市人民医院骨外一科行初次单侧TKA的154例重度膝关节骨关节炎患者(病例纳入标准为年龄在60~80岁的仅行单侧TKA手术的膝关节重度骨关节炎患者;排除标准为TXA或罗哌卡因药物过敏、血液指标异常或者相关数据缺失的患者),分为2组。其中TKA术中采用关节腔周围注射1 g TXA以及100 mg罗哌卡因的共80例(传统组),采用股骨远端与胫骨近端骨膜下注射1 g TXA以及100 mg罗哌卡因的患者74例(改良组),比较两组患者的术中失血量、总失血量、术后3 d血红蛋白(Hb)下降值、术后1、2、3、7以及14 d的视觉模拟评分(VAS)、术后并发症发生率、手术时间和住院时间等指标。采用t检验和卡方检验等行统计分析。

结果

154例患者术后均未出现明显并发症。两组患者一般情况、术前血红蛋白、术前VAS评分、手术时间以及住院时间结果差异无统计学意义(均为P>0.05)。两组术中出血量差异无统计学意义(P>0.05);改良组总失血量(t=5.476)、术后3 d的Hb下降值(t=3.705)低于传统组(均为P<0.05)。术后不同时间(1、2、3、7和14 d)不同状态下疼痛VAS评分比较发现,改良组的术后VAS评分在膝关节静息状态(F=13.512)和屈曲状态(F=18.185)均比传统组更小(均为P<0.001)。

结论

骨膜下注射TXA及罗哌卡因可有效减少TKA手术失血量,并明显减轻术后早期疼痛。

Objective

To investigate the effect of subperiosteal injection of tranexamic acid (TXA) combined with ropivacaine in unilateral total knee arthroplasty (TKA).

Methods

A retrospective analysis was carried out on 154 patients with severe knee osteoarthritis who underwent unilateral TKA in the No.1 Department of Orthopaedic Surgery, Jieyang People's Hospital from January 2017 to January 2021. Inclusion criteria: age from 60 to 80 years with severe knee osteoarthritis, undergoing unilateral TKA only; exclusion criteria: allergy to TXA or ropivacaine, abnormal blood parameters, or data missing. The patients were divided into two groups. Among them, 80 patients were injected with one gram TXA and 100 mg ropivacaine around the joint cavity during TKA operation (the traditional group), and subperiosteal injection of one gram TXA and 100 mg ropivacaine was applied at the distal femur and proximal tibia in 74 patients (the modified group). The intraoperative blood loss, total blood loss, hemoglobin (Hb) decreasing in three days after surgery, the visual analogue score (VAS) on one, two, three, seven, and 14 days after the surgery, the incidence of postoperative complications, operation time, and hospitalization time were compared between the two groups. Statistical analysis was performed using t test and chi square test.

Results

No obvious complication occurred in 154 patients. There was no statistically significant difference in the general condition, preoperative Hb, preoperative VAS score, operation time, or hospitalization time between the two groups (all P>0.05). The amounts of blood loss of the two groups showed no statistically significant difference (P>0.05); the total blood loss (t=5.476, P<0.05) and the decrease of Hb three days after the operation (t=3.705, P<0.05) in the modified group were lower than those in the traditional group. The repeated measures ANOVA on the VAS scores in the resting state and joint flexion state of two groups on one, two, three, seven, and 14 days showed that the modified group reported less postoperative pain than the conventional group both at rest (F=13.512, P<0.001) and in knee flexion (F=18.185, P<0.001).

Conclusion

Subperiosteal injection of TXA and ropivacaine can effectively reduce blood loss during TKA surgery and significantly reduce early postoperative pain.

图2 传统组在关节周围软组织中注射氨甲环酸和罗哌卡因
表1 两组患者的一般资料比较
表2 两组患者全膝关节置换术后出血情况的比较(±s)
表3 两组患者全膝关节置换术后关节静息状态下VAS评分的比较(±s)
表4 两组患者全膝关节置换术后关节屈曲状态下VAS评分的比较(±s)
[1]
Cushnaghan J, Bennett J, Reading I, et al. Long-term outcome following total knee arthroplasty: a controlled longitudinal study[J]. Ann Rheum Dis, 2009, 68(5): 642-647.
[2]
Lützner J, Kasten P, Günther KP, et al. Surgical options for patients with osteoarthritis of the knee[J]. Nat Rev Rheumatol, 2009, 5(6): 309-316.
[3]
Abularrage CJ, Weiswasser JM, Dezee KJ, et al. Predictors of lower extremity arterial injury after total knee or total hip arthroplasty[J]. J Vasc Surg, 2008, 47(4): 803-807,dicussion 807-808.
[4]
Slover J, Lavery JA, Schwarzkopf R, et al. Incidence and risk factors for blood transfusion in total joint arthroplasty: analysis of a statewide database[J]. J Arthroplasty, 2017, 32(9): 2684-2687.e1.
[5]
Leiss F, Götz JS, Maderbacher G, et al. Pain management of unicompartmental (UKA) vs. total knee arthroplasty (TKA) based on a matched pair analysis of 4144 cases[J/OL]. Sci Rep, 2020, 10(1): 17660. DOI:10.1038/s41598-020-74986-x.
[6]
Lützner J, Gehring R, Beyer F. Slightly better pain relief but more frequently motor blockade with combined nerve block analgesia compared to continuous intraarticular analgesia after total knee arthroplasty[J]. Knee Surg Sports Traumatol Arthrosc, 2020, 28(4): 1169-1176.
[7]
Lloyd TD, Neal-Smith G, Fennelly J, et al. Peri-operative administration of tranexamic acid in lower limb arthroplasty: a multicentre, prospective cohort study[J]. Anaesthesia, 2020, 75(8): 1050-1058.
[8]
Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid in total joint arthroplasty:the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society[J]. Reg Anesth Pain Med, 2019, 44(1): 7-11.
[9]
Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement[J]. Br J Anaesth, 2003, 90: 596-599.
[10]
Amundson AW, Johnson RL, Abdel MP, et al. A three-arm randomized clinical trial comparing continuous femoral plus single-injection sciatic peripheral nerve blocks versus periarticular injection with ropivacaine or liposomal bupivacaine for patients undergoing total knee arthroplasty[J]. Anesthesiology, 2017, 126(6): 1139-1150.
[11]
Danoff JR, Goel R, Henderson RA, et al. Periarticular ropivacaine cocktail is equivalent to liposomal bupivacaine cocktail in bilateral total knee arthroplasty[J]. J Arthroplasty, 2018, 33(8): 2455-2459.
[12]
Ross JA, Greenwood AC, Sasser IP. Periarticular injections in knee and hip arthroplasty: where and what to inject[J]. J Arthroplasty, 2017, 32(9, S): S77-S80.
[13]
Gross JB. Estimating allowable blood loss: corrected for dilution[J]. Anesthesiology, 1983, 58(3): 277-280.
[14]
Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults[J]. Surgery, 1962, 51(2): 224-232.
[15]
李林涛,吴海山,吴宇黎,等.人工关节置换术围手术期的血液管理策略[J].中国修复重建外科杂志201529(6):772-776.
[16]
刘金望,林炎水,蒋涛,等.氨甲环酸对老年陈旧性股骨颈骨折伴骨质疏松行髋关节置换术失血的影响[J].中国老年学杂志201737(1):148-150.
[17]
孙世伟,杨隆,谢水安,等.静脉联合局部应用氨甲环酸在全髋关节置换中的作用[J].中国组织工程研究201620(48):7149-7155.
[18]
胡舒,张志奇,张紫机,等.氨甲环酸对全髋关节置换术的影响[J/CD].中华关节外科杂志(电子版)201610(6):604-608.
[19]
王宇,朱云章,刘刚.高龄患者髋、膝关节置换中罗哌卡因腰椎硬膜外麻醉的镇痛效果[J].中国组织工程研究201519(13):1990-1994.
[20]
高向利.分析腰椎硬膜外联合在下肢骨关节置换术老年患者中应用罗哌卡因的效果[J].临床研究201927(8):122-124.
[21]
Gandhi HJ, Trivedi LH, Tripathi DC, et al. A randomized, controlled trial of comparison of a continuous femoral nerve block (CFNB) and continuous epidural infusion (CEI) using 0.2% ropivacaine for postoperative analgesia and knee rehabilitation after total knee arthroplasty (TKA)[J]. J Anaesthesiol Clin Pharmacol, 2019, 35(3): 386-389.
[22]
Wang Y, Zhou A. A new improvement: subperiosteal cocktail application to effectively reduce pain and blood loss after total knee arthroplasty[J/OL]. J Orthop Surg Res, 2020, 15(1): 33. DOI:10.1186/s13018-020-1563-5.
[1] 丁莹莹, 宋恺, 金姬延, 田华. 机器人辅助膝髋关节置换术后精细化临床护理[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 553-557.
[2] 任俊筱, 浦路桥, 王志豪, 施洪鑫, 刘爱峰, 齐保闯, 徐永清, 李川. 机器人辅助全膝关节置换术的临床疗效对照研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 469-476.
[3] 许亚龙, 巩栋, 陈晓涛. 超前镇痛在全膝关节置换术中的研究进展[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 517-523.
[4] 王冰, 孙海宁, 于秀淳, 周珂, 翟凯, 苗族康. 膝骨关节炎的活动衬垫型单髁置换疗效与假体生存率[J/OL]. 中华关节外科杂志(电子版), 2024, 18(03): 337-345.
[5] 张江礼, 刘金辉, 潘西庆, 刘光源, 范虓. 全膝关节置换应用智能辅助手术导航系统治疗膝骨关节炎[J/OL]. 中华关节外科杂志(电子版), 2024, 18(03): 346-351.
[6] 杨士慷, 曹光磊. 膝骨关节炎三种术式患者满意度的术前影响因素[J/OL]. 中华关节外科杂志(电子版), 2024, 18(03): 390-397.
[7] 王啸, 李一凡, 沈素红, 曹国瑞, 史小涛, 袁彦浩, 谭红略. 全膝关节置换术后早期下肢深静脉血栓形成的时空规律[J/OL]. 中华关节外科杂志(电子版), 2024, 18(03): 414-420.
[8] 刘浩, 郑清源, 程龙, 辛鹏, 吴博, 任鹏, 张国强. 全膝关节置换术中选择窄版股骨假体的影响因素[J/OL]. 中华关节外科杂志(电子版), 2024, 18(02): 193-200.
[9] 卢芳连, 汤莉, 何河北, 李建云, 欧栓机, 陈燕, 陈娇妹. 责任护士主导的疼痛管理在膝关节置换术后的应用[J/OL]. 中华关节外科杂志(电子版), 2024, 18(02): 285-289.
[10] 赵锦伟, 李晓军, 刘桂宇, 荣晓玲, 黄明利, 宋文静, 高广凌, 鞠昌军. 固定平台假体膝关节单髁置换术中止血带应用策略研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(01): 39-47.
[11] 邓华梅, 袁札根, 曾德荣, 潘珊珊, 张葆青, 欧爱华, 曹学伟. 全膝关节置换术中气压止血带应用效果与影响因素分析[J/OL]. 中华关节外科杂志(电子版), 2023, 17(06): 788-794.
[12] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J/OL]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[13] 苏永涛, 王春雷, 徐广琪, 关中正, 焦伟, 隋颖. 胫骨骨膜牵张术联合富血小板血浆对治疗糖尿病足溃疡的疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 238-244.
[14] 刘佳瑞, 张宇喆, 宁杨. 经前庭沟切口的骨膜下隧道技术在牙龈退缩治疗中的应用[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 143-149.
[15] 袁志静, 黄杰, 何国安, 方辉强. 罗哌卡因联合右美托咪定局部阻滞麻醉在老年腹腔镜下无张力疝修补术中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 557-561.
阅读次数
全文


摘要